|
| Analyst
Scorecard | | Analyst: | Kantor, Jason | EPS
Est. Accuracy: | 
| | Broker: | RBC Capital Markets | Recommendation
Performance: | Not Avl.
|
|
What is this?
This scorecard presents a summary of StarMine ratings
for this analyst.
Ratings are displayed when analysts score highly based
on the accuracy of
their earnings estimates or the returns of their stock
recommendations. Stocks
which appear on this scorecard are limited to those
covered by the analyst for
a significant period of time. Learn
More
|
| |
Industry Coverage
| | |
Industry
|
EPS Est. Accuracy
|
Industry Excess Return
|
Industry Return
| | | |
Biotechnology
|
|
6.2%
| Not Avl.
| | | |
| |
EPS Estimate Accuracy
| | |
Symbol
|
Company Name
|
EPS Est. Accuracy
|
No. Analysts
| | | |
AFFY
|
Affymax Inc
|
|
7
| | | | |
ALTH
|
Allos Therapeutics
|
|
9
| | | | |
ALXA
|
Alexza Pharmaceuticals Inc
| 
|
4
| | | | |
BIIB
|
Biogen Idec Incorporated
|
|
21
| | | | |
CBST
|
Cubist Pharmaceuticals Inc
|
|
12
| | | | |
CRIS
|
Curis Incorporated
|
|
4
| | | | |
GILD
|
Gilead Sciences Inc
|
|
22
| | | | |
IMGN
|
Immunogen Inc
|
|
6
| | | | |
MDCO
|
Medicines Company
|
|
5
| | | | |
MITI
|
Micromet Inc
|
|
7
| | | | |
PCYC
|
Pharmacyclics Inc
|
|
1
| | | | |
RIGL
|
Rigel Pharmaceuticals
|
|
11
| | | | |
SGEN
|
Seattle Genetics Inc
|
|
9
| | | | |
SNSS
|
Sunesis Pharmaceuticals Inc
|
|
3
| | | | |
XOMA
|
Xoma Ltd
|
|
5
| | | |
| Other Stocks Covered
| |
Celgene Corporation (CELG), Osi Pharmaceuticals Inc (OSIP), Vertex Pharmaceuticals Inc (VRTX)
|
| | |
|
|
|